SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001493152-23-034839
Filing Date
2023-09-29
Accepted
2023-09-29 16:05:09
Documents
1
Period of Report
2023-09-29

Document Format Files

Seq Description Document Type Size
1 formpre14a.htm PRE 14A 809221
  Complete submission text file 0001493152-23-034839.txt   810334
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

IRS No.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-39717 | Film No.: 231295486
SIC: 2834 Pharmaceutical Preparations